TEAM HALLAHAN LLC for ALKERMES, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FY 2021 Appropriations (LHHS, CJS, Interior, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions in HR 3, Lower Drug Costs Now Act of 2019 and S 2543, Prescription Drug Pricing Reduction Act of 2019.
Foreign entity interest: Alkermes PLC is a Foreign Parent with tangential interests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATE HALLAHAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.